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ABSTRACT
Genomic imprinting is an epigenetic phenomenon
leading to parental allele-specific expression.
Dosage of imprinted genes is crucial for normal de-
velopment and its dysregulation accounts for sev-
eral human disorders. This unusual expression pat-
tern is mostly dictated by differences in DNA methy-
lation between parental alleles at specific regula-
tory elements known as imprinting control regions
(ICRs). Although several approaches can be used for
methylation inspection, we lack an easy and cost-
effective method to simultaneously measure DNA
methylation at multiple imprinted regions. Here, we
present IMPLICON, a high-throughput method mea-
suring DNA methylation levels at imprinted regions
with base-pair resolution and over 1000-fold cover-
age. We adapted amplicon bisulfite-sequencing pro-
tocols to design IMPLICON for ICRs in adult tissues
of inbred mice, validating it in hybrid mice from recip-
rocal crosses for which we could discriminate methy-
lation profiles in the two parental alleles. Lastly, we
developed a human version of IMPLICON and de-
tected imprinting errors in embryonic and induced
pluripotent stem cells. We also provide rules and
guidelines to adapt this method for investigating the
DNA methylation landscape of any set of genomic
regions. In summary, IMPLICON is a rapid, cost-
effective and scalable method, which could become
the gold standard in both imprinting research and
diagnostics.
INTRODUCTION
Genomic imprinting describes the parent-of-origin depen-
dent monoallelic expression of ∼100–200 genes in mam-
mals (reviewed in (1)). The inherited set of maternal and
paternal chromosomes are not equivalent and are both re-
quired for full-term development (2,3). This effect maps
to specific chromosomal regions (4), which later were dis-
covered to contain imprinted genes (5–8). Imprinted genes
are important regulators of foetal growth and development
(reviewed in (9,10)) and involved in several postnatal en-
docrine and metabolic pathways, as well as in neuronal
functions affecting behaviour and cognition (reviewed in
(1)). Not surprisingly, genetic or epigenetic disturbances re-
sulting in altered dosage of imprinted genes lead to severe
developmental, neurological and metabolic diseases in hu-
mans (reviewed in (11,12)), such as the Prader-Willi (PWS)
(OMIM#176270) and Angelman (AS) (OMIM#105830)
syndromes caused by defects in the paternal or maternal
chr15q11-q13 region, respectively (reviewed in (13,14)).
Most imprinted genes are located in clusters through-
out the genome, containing a cis-acting CpG-rich DNA
element referred to as imprinting control region (ICR)
(reviewed in (1)). The ICR is epigenetically marked by
DNA methylation in a parent-of-origin fashion, which cor-
relates with expression and/or silencing of the surround-
ing imprinted genes. Deletions of ICRs result in the loss
of parental allele-specific expression within an imprinted
cluster (15,16). ICRs acquire parental-allele specific DNA
methylation in the germline, which are maintained through-
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out development and adulthood, resisting the global wave
of demethylation and de novo methylation steps during
early embryonic development (reviewed in (1,17,18)). The
preservation of parental allele-specific methylation at ICRs,
also known as germline differentially methylated regions
(gDMRs), is fundamental for the correct maintenance of
imprinted expression throughout life.
Despite their importance, there is currently no robust,
cost-effective and high-throughput method to assess the
methylation status of ICRs across multiple imprinted re-
gions (Supplementary Table S1; reviewed in (19)). DNA
methylation is commonly assessed using methods based on
bisulfite sequencing (20). Treatment of DNA with sodium
bisulfite results in deamination of unmodified cytosines to
uracils, whereas methylated cytosines remain unchanged.
Traditionally, this is followed by PCR amplification of
a region of interest followed by subcloning and Sanger
sequencing––a laborious and costly process when consider-
ing multiple samples or viewpoints. Alternatively, bisulfite-
treated DNA can be converted into a next-generation se-
quencing library to give genome-wide information, which
is expensive when at least 10-fold genomic coverage is re-
quired to accurately determine methylation levels at individ-
ual ICRs (21,22). This can be somewhat mitigated using re-
duced representation bisulfite sequencing (RRBS) to enrich
for CpG-rich regions of the genome including imprinted re-
gions (23,24), or array-based methods, as the Illumina In-
finium methylation BeadChip (25). These methods, how-
ever, take several weeks, require advanced analysis skills and
are not feasible to be routinely performed at scale. At the
other end, pyrosequencing analysis of bisulfite converted
DNA provides an easier method to analyse a few (<5) CpGs
within ICRs, but is not high-throughput (26). Bisulfite-
free approaches have also been used to study genomic im-
printing such as genome-wide Methylated DNA Immuno-
precipitation sequencing (MeDIP-seq) (27,28) and Enzy-
matic Methyl-seq (EM-seq) (29). An advantage of EM-seq
or other similar bisulfite-free methods such as Tet-assisted
pyridine borane (TAPS-seq) (30) is that they can be cou-
pled with long read sequencing (EM-LR-seq and lrTAPS)
(29,31) overcoming the limitation of read length unavoid-
able in bisulfite methods that lead to DNA fragmentation.
Long read sequencing itself using Oxford Nanopore can
directly detect methylated Cs to measure parental allele-
specific methylation on long stretches of DNA (32), how-
ever this or analogous technology such as PacBio Single-
Molecule Real-Time (SMRT) are still hindered by limited
coverage or throughput and high costs (33).
Importantly, in recent years, researchers have adapted
the traditional bisulfite-PCR method amplification involv-
ing subcloning and Sanger sequencing to have a next-
generation sequencing output (34). This targeted deep
bisulfite sequencing approach addresses many of the short-
falls of other methods, enabling regions of interest to be
probed in a fast, cost-effective and high-resolution man-
ner. We reasoned that adapting this amplicon method to as-
sess genomic imprints will provide an invaluable and much
needed tool for the experimental and clinical science com-
munities.
Here, we present IMPLICON (IMPrint ampLICON), an
ultra-deep sequencing method to robustly measure DNA
methylation levels with base-pair resolution at imprinted
regions. This method uses bisulfite-treated DNA to gener-
ate amplicon sequencing libraries covering most murine and
human imprinted regions. This way, IMPLICON generates
base-resolution datasets with over 1000-fold coverage that
can be quickly and easily analysed to determine genomic
imprinting fidelity in <6 days. Furthermore, we provide de-
tailed instructions to analyse the data, and rules for design-
ing additional primer sequences, making this method eas-
ily adaptable to analyse DNA methylation patterns at other
genomic regions of interest. We expect that this rapid, scal-
able and cost-effective ultra-deep sequencing method will




Inbred mouse genomic DNA samples were obtained from
the Babraham Institute C57BL/6 (BL6) J/Babr Ageing
Mouse Colony as previously described (35). Genomic DNA
samples from F1 hybrid animals were obtained from BL6
× CAST/EiJ (CAST) reciprocal crosses from the iMM JLA
Rodent Facility. Animals were housed in a maximum of four
per cage in a temperature-controlled room (24◦C) with a 12-
h light/dark cycle. Animals were fed standard CRM (P) VP
diet and both food diet and water were available ad libitum.
All experiments involving mice were carried out in accor-
dance with the UK and Portugal Government Home Office
licensing procedures.
Genomic DNA from human peripheral blood was col-
lected from two healthy female volunteers via fingerprick.
Human embryonic stem cells (ESC) genomic material was
collected from H9-KN2 (Nanog-Klf2) ESCs (36) and cul-
tured in six-well dishes under naı̈ve (N2B27 supplemented
with human LIF, 1 mM Chir, 1 mM PD03 and 2 mM
Go6983 on MEF feeder cells) and primed (Vitronectin in
E8 media) conditions as previously described (37). Ge-
nomic material was also obtained from human primary fi-
broblasts (AS Fib. and Ctrl Fib.) and respective induced
pluripotent stem cell (iPSC) (Ctrl D, Ctrl E, AS A, AS
B, AS D and AS E) lines from an Angelman patient and
sex- and age-matched healthy individual as previously de-
scribed (38). Briefly, primary fibroblasts were maintained in
DMEM supplemented with 10% fetal bovine serum, 1 mM
L-glutamine and 100 units/ml penicillin, 100 g/ml strepto-
mycin (Life Technologies). iPSCs were cultured in mTeSR1
medium (STEMCELL Technologies) supplemented with
50 units/ml penicillin, 50 g/ml streptomycin (Life Tech-
nologies) in Matrigel (Corning)-coated plates. All cell lines
grew in a humid incubator at 37◦C with 5% (v/v) CO2.
DNA extraction and bisulfite treatment
Genomic DNA was isolated using either conventional phe-
nol:chloroform:isoamyl alcohol extraction, the DNeasy
Blood and Tissue Kit (Qiagen) or the AllPrep DNA/RNA
Micro Kit (Qiagen) according to manufacturer’s instruc-
tions and eluted into TE buffer or H2O. 1g of genomic
DNA was bisulfite converted using the EZ DNA methyla-
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instructions with either magnetic bead or column clean-up
and eluted in 66 l elution buffer to obtain a final concen-
tration of ∼15 ng/l bisulfite-converted DNA.
IMPLICON primer design and testing
Genomic coordinates for murine ICRs or other differen-
tially methylated regions of interest (gDMRs or somatic
differentially methylated regions – sDMRs) were obtained
from the former webpage, https://atlas.genetics.kcl.ac.uk,
and validated using in-house DNA methylation datasets.
Appropriate SNPs in the vicinity of ICRs were acquired
either from the literature (39) or from https://www.sanger.
ac.uk/sanger/Mouse SnpViewer/rel-1505. Human imprint-
ing genomic coordinates for gDMRs were defined using
oocyte and sperm methylomes (40). Genomic DNA se-
quences of the regions of interest were obtained from
UCSC Genome Browser (https://www.genome.ucsc.edu)
and imported into MethPrimer (https://www.urogene.org/
methprimer/) (41) or BiSearch (http://bisearch.enzim.hu/)
(42). For each region, at least two primer pairs for bisul-
fite sequencing PCR were designed, selecting those with
smaller product size (optimal size 300 bp, max 430 bp),
a minimum of five CpGs in the PCR product, and no
CpGs within the PCR primers. The following sequence
was added to the forward (CTACACGACGCTCTTCCG
ATCT) and reverse (TGCTGAACCGCTCTTCCGATCT
NNNNNNNN) primers (where N denotes a random nu-
cleotide to generate a unique molecular identifier -UMI).
Each primer pair PCR condition combination was tested
on 2 ng bisulfite-treated genomic DNA, 0.3 M forward
and reverse primer and 2× KAPA HiFi Uracil+ ReadyMix
with the following conditions: initial denaturation at 95◦C
for 5 min, 30–35 cycles of 98◦C denaturation for 20 s, vari-
able annealing temperature for 15 s and extension at 72◦C
for 60 s; followed by a final extension at 72◦C for 10 min.
The annealing temperature was tested between 60 and 72◦C.
PCR products were run on a 1% agarose–TAE gel and those
yielding a single strong band were selected for inclusion in
the amplicon assay. Approximately 50% of designed primers
yield a single strong band under these conditions. The use of
2× KAPA HiFi Uracil+ ReadyMix is crucial to ensure effi-
cient amplification despite the lower complexity of bisulfite-
treated DNA.
IMPLICON library preparation
The IMPLICON protocol consists of two PCR reactions.
In the first reaction, each sample is amplified with each
primer pair in individual reactions: 30 ng (2 l of 66 l
eluted) of bisulfite-treated DNA) is amplified with 1.2 l
of a 10 M primer pool (final 1.5 M), containing both
forward and reverse primers, and 4 l of 2× KAPA HiFi
Uracil+ ReadyMix in a final volume of 8 l. The hybrid
mouse samples were processed in a final volume of 16 l.
While lower starting amounts of bisulfite-treated DNA can
be used, we do not recommend this as it may not accurately
reflect DNA methylation levels of the original population
and may not make use of the full sequencing depth of IM-
PLICON due to a higher duplication rate. DNA was am-
plified using the following conditions: initial denaturation
at 95◦C for 5 min, 30 cycles of 98◦C denaturation for 20
s, variable annealing temperature for 15 s and extension at
72◦C for 60 s; followed by a final extension at 72◦C for 10
min. Annealing temperatures for each primer pair were op-
timized as described above and are listed in Supplementary
Table S2. All PCR reactions for each individual sample were
pooled together and cleaned-up using 1.5× AMPure XP
beads and eluted in 20 l H2O. In the second PCR reaction,
barcoded Illumina adapters are attached to the pooled PCR
samples ensuring that each sample pool receives a unique
reverse barcoded adapter. The 20 l PCR pool was ampli-
fied using 1 l of 10 M Illumina PE1.0 primer (same for all
samples), 1 l of 10 M Illumina iTAG primer (distinct for
each sample) and 25 l 2× KAPA HiFi Uracil+ ReadyMix
in a 50 l reaction using the following conditions: initial de-
naturation at 98◦C for 45 s, 5 cycles of 98◦C denaturation for
15 s, 65◦C annealing for 30 s and extension at 72◦C for 30 s;
followed by a final extension at 72◦C for 5 min. Reactions
were cleaned-up with 1x AMPure XP beads and eluted in
20 l H2O. Libraries were verified by running 1:30 dilutions
on an Agilent bioanalyzer. Note that the profile of these li-
braries is spikey due to their amplicon nature (Supplemen-
tary Figure S1C). Libraries were sequenced using the Illu-
mina MiSeq platform to generate paired-end 250 bp reads
using 10% PhIX spike-in as the libraries are of low complex-
ity.
IMPLICON sequencing analysis
Data was processed using standard Illumina base-calling
pipelines. As the first step in the processing, the first 8
bp of Read 2 were removed and written into the readID
of both reads as an in-line barcode or UMI. This UMI
was then later used during the de-duplication step with
‘deduplicate bismark –barcode mapped file.bam’. Raw se-
quence reads were then trimmed to remove both poor
quality calls and adapters using Trim Galore (v0.6.2
for hybrid mouse tissues, v0.4.4 for human and in-
bred mouse tissues, www.bioinformatics.babraham.ac.uk/
projects/trim galore/, Cutadapt version 2.3 for hybrid
mouse tissues, v1.9.1 for human and inbred mouse tis-
sues, parameters: –paired). Trimmed reads were aligned
to the mouse or human reference genome in paired-
end mode. Alignments were carried out with Bismark
v0.14.4 for hybrid mouse tissues and v0.18.2 for human
and inbred mouse tissues (43). CpG methylation calls
were extracted from the mapping output using the Bis-
mark methylation extractor (v0.22.1 for hybrid mouse tis-
sues, v0.18.2 for human and inbred mouse tissues). De-
duplication was then carried out with deduplicate bismark,
using the –barcode option to take UMIs into account (see
above). For hybrid mouse strain experiments, the data was
aligned to a hybrid genome of BL6/CAST (the genome
was prepared with the SNPsplit package (v0.3.4, https:
//github.com/FelixKrueger/SNPsplit). Following alignment
and de-duplication, reads were split allele-specifically with
SNPsplit. Aligned read (.bam) files were imported into Se-
qmonk software (http://www.bioinformatics.babraham.ac.
uk/projects/seqmonk) for all downstream analysis. Probes
were made for each CpG contained within the amplicon and
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count options. Downstream analysis was performed using
Excel and GraphPad.
From the raw data deposited in GEO under the ac-
cession number GSE146129, the reads mapped to the
following murine (mm10) and human (hg38) genomic
coordinates were excluded for consideration in this article
for one of the following reasons: (i) failure to reach the
coverage threshold (>100 reads); (ii) clear sequencing
bias towards the methylated or unmethylated amplicons
or to one of the SNPs, (iii) regions out of the scope
of this article. For inbred mice data: Chr1:63264732–
63264796, Chr2:152686485–152686582, Chr2:174328905–
174329102, Chr6:4746303–4746438, Chr6:58906821–
58907146 and Chr17:12742173–12742420; for hybrid
mice data: Chr6:4746303–4746438, Chr18:12973031–
12973038 and Chr18:36988436–36988740; for human data:
Chr19:16555181–16555319, Chr3:181712902–181713043
and Chr20:37521191–37521391.




To surpass the current limitations for methylation analy-
sis at imprinted regions, we adapted bisulfite-treated am-
plicon next-generation sequencing (NGS) approaches for
these loci, naming our method IMPrint ampLICON or
IMPLICON (Figure 1A–C). We designed primers target-
ing well characterized murine imprinted regions and added
adapter sequences to allow for efficient library construction
(see Materials and Methods). The following rules were used
for primer design: (i) primer sequences do not contain CpGs
to ensure both methylated and unmethylated alleles are am-
plified equally; (ii) the maximum size of amplified regions
is ideally <300 bp and no >430 bp to reduce any bias in-
troduced from bisulfite treatment-induced DNA fragmen-
tation; (iii) amplified regions contain a minimum of five
CpGs and (iv) primers yield a single PCR product when
tested on bisulfite-treated genomic DNA (Supplementary
Figure S1A, B; Table S2). We also designed control primers
against regions consistently unmethylated (promoter and
5′end of Sox2 and Klf4 genes) and methylated (intronic
CpG-rich region of the Pcdha gene cluster and last exon
of the Prickle1 gene) in mouse ESCs to control for bisul-
fite conversion efficiency (Supplementary Table S2). Impor-
tantly, and in contrast to previous amplicon bisulfite se-
quencing methods (34), primers also included a random 8
nucleotide barcode or UMI to enable post-sequencing data
de-duplication. Primers were individually validated to give
a single product on bisulfite-treated genomic DNA from
mouse embryonic stem cells (ESCs) or tissue samples (Sup-
plementary Figure S1A, B), resulting in 15 primer pairs cov-
ering nine murine imprinted clusters (Figure 1A; Supple-
mentary Table S2).
The IMPLICON method consists of two PCR reactions.
The first PCR is an individual reaction for each primer pair
which are then pooled together by sample, followed by a
second PCR using barcoded Illumina adapters for sam-
ple identification (Figure 1C, see Materials and Methods).
Representative bioanalyzer traces after the first and second
PCRs are displayed in Supplementary Figure S1C. The final
set of 19 primer pairs generate PCR products sampling a to-
tal of 245 CpGs (range from 5 to 23, on average 13 CpGs per
amplicon) (Supplementary Table S2). Up to 32 samples can
be easily processed simultaneously to generate an amplicon
library in just 2–3 days, which is subsequently sequenced on
an Illumina MiSeq platform (Figure 1C).
IMPLICON in inbred mice
As a proof of principle, we analysed DNA methyla-
tion levels in mouse organs (heart, liver and lung) from
three independent adult male C57BL/6J mice of differ-
ent ages (3 months, 6 months and 15 months) for which
imprints are well known to be maintained (50%:50%
methylated/unmethylated ratio) (22,44,45). With just one
MiSeq run, we were able to examine each CpG within the
selected genomic regions with an average of ∼4900-fold cov-
erage after post-sequencing de-duplication. The UMI in the
PCR primer enabled us to control for PCR amplification
bias which ranged from a minimum of 0.6% to a maximum
of 72.1% of duplicated reads (median of 18.2%) (Supple-
mentary Table S3). Importantly, this enabled us to deter-
mine if methylated and unmethylated reads were amplified
to the same extent. With our selected primers, we saw very
little, if any, changes in overall DNA methylation levels be-
fore and after de-duplication (Supplementary Figure S2).
Furthermore, the de-duplication step guarantees that each
original DNA molecule is measured only once in the final
dataset, ensuring the ultra-deep dataset has single-molecule
resolution.
As predicted, both unmethylated (Sox2 and Klf4) and
methylated controls (Pcdha and Prickle1) showed, respec-
tively, low (<∼10%) or high (>∼90%) levels of DNA
methylation for all tested tissues in the three individuals
(Figure 2A; Supplementary Table S3). In contrast, we ob-
served DNA methylation levels of ∼50% for Dlk1-Dio3 and
Gnas imprinted regions that did not change as a function of
the organ or age (Figure 2A). Examining DNA methylation
consistency for each read confirmed that the 50% methyla-
tion levels reflected an equal mix of unmethylated (<∼10%)
and methylated (>∼90%) reads as expected for imprinted
regions (Figure 2B). DNA methylation levels of ∼50% were
also seen for all other imprinted regions analysed by IM-
PLICON (Figure 2C, Supplementary Table S3).
IMPLICON in hybrid mice from reciprocal crosses
To validate the parent-of-origin methylation differences,
single nucleotide polymorphisms (SNPs) of hybrid mouse
crosses were used to differentiate between maternal and pa-
ternal reads. We generated reciprocal crosses of two dis-
tinct mouse strains, BL6 and CAST, which are widely used
for allele-specific studies owing to the frequent presence of
SNPs (22,46) (Figure 3A). From the original set of primers
used in inbred mice, only six contained appropriate SNPs
within the amplified region. Thus, we redesigned 10 more
primer pairs according to the rules above to include SNPs
not masked by bisulfite conversion (C/T SNPs were ex-
cluded) within the region of interest, covering 13 imprinted
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Figure 1. The IMPLICON method. (A) Schematic view of the murine karyotype depicting the location of the regions detected by IMPLICON; black
arrowheads – control regions; red arrowheads – imprinted regions. (B) Schematic representation of the mouse Dlk1-Dio3 imprinted cluster; Mat – Ma-
ternal inherited chromosome; Pat – Paternal inherited chromosome; ICR – imprinting control region; red arrows – primers to amplify Dlk1-Dio3 ICR;
genomic region is not drawn to scale. (C) Brief scheme of the IMPLICON method and its approximate timeline; bisulfite treatment of genomic DNA
converts unmethylated cytosines to uracils (yellow letters), whilst methylated cytosines are retained as cytosines (white letters). Two rounds of PCR are
then performed: the first PCR amplifies each region for each sample separately and adds eight random nucleotides (N8) for data de-duplication and adapter
sequences; after pooling amplicons for each biological sample, a second PCR completes a sequence-ready library with sample-barcodes for multiplexing.
White lollipops – unmethylated CpGs; black lollipops – methylated CpGs; black DNA strand – targeted strand for amplification; light grey DNA strand –
strand not targeted for amplification; Dark grey and green boxes - primers annealing the targeted strand (dark grey), containing adapter sequences (green);
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Figure 2. IMPLICON in adult tissues from C57BL/6J mice. (A) Methylation analysis of Sox2 (unmethylated control), Prickle1 (methylated control), and
the Dlk1-Dio3 and Gnas ICRs in heart, lung and liver tissues from adult mice of different ages: 3 months, 6 months and 15 months; Graph represents the
mean ± SD methylation levels measured at each CpG within each genomic region for each individual mouse; dashed line marks 50% level of methylation.
(B) Plot displaying methylated and unmethylated CpGs for each CpG position (in columns) in all the individual reads (in rows) for both the Dlk1-Dio3 and
Gnas (for the Gnas SNP primer) imprinted loci in the heart, lung and liver of a 3-month-old mouse. (C) Heatmap displaying average methylation levels at
individual imprinted regions and controls (in columns) from adult mice of different ages (in rows) in heart, lung and liver.
(see Materials and Methods; Supplementary Figure S3; Ta-
ble S2)
We tested this allele-specific version of IMPLICON in
different organs (heart, liver, brain and ear) from two F1
hybrid BL6/CAST adult male mice from reciprocal crosses
(BL6 female × CAST male and vice-versa). We gener-
ated IMPLICON libraries with an average allelic cover-
age across the sampled CpGs that reached as high as
20 000-fold. Importantly, roughly the same proportion of
reads were assigned to both the BL6 (51.26%) and CAST
(48.54%) genomes, arguing against amplification bias with
only 0.20% of reads left unassigned (Supplementary Table
S3).
For the unmethylated (Sox2 and Klf4) and methy-
lated (Prickle1) controls, our results show, respectively, low
(<∼10%) or high (>∼90%) methylation levels in both ma-
ternal and paternal hybrid alleles in the heart, but also the






/nar/article/48/16/e92/5867412 by guest on 23 February 2021




Figure 3. Allele-specific IMPLICON in F1 adult tissues from C57BL/6J x Cast/EiJ reciprocal crosses. (A) Schematic representation of the Igf2r imprinted
cluster; Mat – Maternally inherited chromosome; Pat – Paternally inherited chromosome; ICR – imprinting control region; red arrows – primers to amplify
Igf2r ICR; in the scheme below, a single nucleotide polymorphism is highlighted in red; genomic region not drawn to scale. (B) Methylation analysis of
Sox2 (unmethylated control), Prickle1 (methylated control) and ICRs of imprinted regions in the heart from F1 hybrid adult mice derived from C57BL/6J
× CAST/EiJ reciprocal crosses; Graph represents the mean ± SD methylation levels measured at each CpG within different genomic regions per parental
allele in the two F1 hybrid mice; Scheme on the left of each graph represents the expected methylation status of each region (white lollipops – unmethylated
CpGs; black lollipops – methylated CpGs; Mat – maternal allele; Pat – paternal allele; black mice (BL6) – C56BL/6J strain; brown mice (CAST) –
CAST/EiJ strain; regions are not drawn to scale. (C). Methylation analysis for the Igf2r imprinted cluster in heart, ear, brain and liver of F1 hybrid mice
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dent in the control regions, we turned our attention to ICRs.
As exemplified in Figure 3B, at the Dlk1-Dio3 and Igf2-
H19 (paternally methylated) and Peg3, Commd1-Zrsr1, Im-
pact, Kcnq1-Kcnq1ot1 and Plagl1/Zac1 (maternally methy-
lated) ICRs in the heart the maternal allele was always un-
methylated or methylated, respectively, independent of the
strain-specific SNP. These parental allele-specific methyla-
tion patterns were unequivocally shown for all imprinted re-
gions analysed in the four tissue samples of the same mouse
(Supplementary Table S3) as exemplified for the maternally
methylated Igf2r locus (Figure 3C). In summary, we were
able to adapt the IMPLICON method for the screening of
methylation at multiple ICRs with allelic discrimination.
Human IMPLICON
After our success in implementing IMPLICON for mouse
imprinted regions, we created a human version of IMPLI-
CON. Published methylome data from human oocytes and
sperm (40) were analysed to accurately determine the ge-
nomic coordinates of gDMRs. As controls for bisulfite con-
version, we included amplicons targeting regions fully un-
methylated (promoter and TSS of KLF4) or methylated
(last exon of RHOG) in primed human ESCs (hESCs) (Sup-
plementary Figure S4; Table S2). Unfortunately, for some
regions, such as the DLK1-DIO3 locus, we were unable to
design specific primers according to our rules, which can
be due to high repeat or CpG density in these regions.
Nonetheless, we were able to capture 14 human imprinted
clusters (12 oocyte gDMRs and 2 sperm gDMRs) using 16
primer pairs, in addition to the control regions.
We first tested these primers in blood samples from two
healthy individuals. Once again, we obtained high coverage
for the CpGs analysed (average of ∼6500-fold). Our un-
methylated and methylated controls showed generally low
levels of DNA methylation for KLF4 (<∼10%) and high
levels of methylation for RHOG (>∼90%) (Figure 4A). As
expected, all the gDMRs inspected showed methylation lev-
els of ∼50% (Figure 4A) reflecting an equal mix of methy-
lated (>∼90%) and unmethylated (>∼10%) reads in accor-
dance with normal imprinting patterns (Figure 4B). Over-
all, these results suggest that our IMPLICON approach is
suitable to look at multiple human imprinted regions.
Then, we used IMPLICON to assess imprinting fidelity
in different hESC culture conditions. Human ESCs cul-
tured in naı̈ve conditions have globally lower levels of DNA
methylation (∼30% compared to 70–80% in conventional
or primed hESC cultures). As a result, loss of imprint-
ing methylation is frequently observed in naı̈ve conditions,
whilst primed hESCs are more able to maintain imprinting
fidelity (47–49). In our IMPLICON results, the unmethy-
lated control region (KLF4) showed <∼10% methylation as
anticipated (Figure 4C). Reflecting the expected global lev-
els of DNA methylation, the RHOG methylated control re-
gion showed higher (>∼90%) levels of DNA methylation in
primed hESCs, in comparison to naı̈ve hESCs (∼50%) (Fig-
ure 4C). Of the 14 imprinted regions analysed, 8 showed the
expected 50% DNA methylation levels in primed hESC cul-
tures, whereas only three imprinted loci (DIRAS3, PLAGL1
and RB1) maintained DNA methylation in naı̈ve hESCs
(Figure 4C). Naı̈ve hESCs tend to lose DNA methylation,
with 10 imprinted regions having less than the 40–60% ex-
pected DNA methylation levels, compared to just one lo-
cus, FAM50B, losing methylation in primed hESCs (Fig-
ure 4C). This was reflected appropriately in the number of
fully methylated and unmethylated reads: at the GRB10 lo-
cus primed hESCs presented the same proportion of these
reads in two biological replicates, while only fully unmethy-
lated reads were seen for naı̈ve hESCs (Figure 4D). In
primed conditions, five regions had close to 100% methyla-
tion (e.g. IGF2-H19), with only one hypermethylated region
(GNAS) seen in naı̈ve hESCs (Figure 4C). IGF2-H19 is a
perfect example of a region fully methylated in primed con-
ditions and completely unmethylated in naı̈ve conditions
(Figure 4D). In summary, our analyses show that IMPLI-
CON can be used successfully to identify imprinting errors
in hESC cultures and furthermore highlights the impor-
tance of checking imprinting fidelity in hESC lines, includ-
ing those in primed conditions.
Next, we ran our human IMPLICON on dermal fi-
broblasts and corresponding human induced pluripotent
stem cell (hiPSC) lines previously generated from an An-
gelman patient and a healthy individual (38) (Figure 5A) to
search for putative imprinting defects often found in hiPSCs
(50–52). As predicted, our unmethylated and methylated
controls showed low (<∼10%) and high levels (>∼90%)
of DNA methylation, respectively (Supplementary Table
S3). We then screened for the SNURF TSS-DMR at the
PWS/AS cluster which is only methylated on the mater-
nally inherited allele and is deleted in the Angelman patient-
derived cells (Figure 5A). While the healthy fibroblasts and
hiPSCs showed the expected ∼50% methylation levels, the
Angelman-derived cells presented ∼0% methylation, con-
sistent with the absence of the methylated maternal SNURF
TSS-DMR region (Figure 5A and B). For the other im-
printed regions sampled, we found values around the ex-
pected ∼50% methylation in healthy and Angelman fi-
broblasts (Figure 5C; Supplementary Table S3). A remark-
able exception was the IGF2R int2-DMR, the gDMR at
the IGF2R imprinted locus, presenting ∼50% methylation
in Angelman patient fibroblasts (and iPSCs), but >∼90%
methylation in the healthy fibroblasts (and correspondent
iPSCs). Interestingly, imprinting at this region is known to
be polymorphic and to differ from individual to individual
(53).
In contrast to stable imprinting associated with somatic
cells, we observed many methylation aberrations at gDMRs
for many of the imprinted clusters in hiPSCs (Figure 5C;
Supplementary Table S3). In addition to hESCs, imprinted
defects have been broadly associated with hiPSCs (50–52)
and are one of the major concerns for the downstream ap-
plications of these cells (54,55). A few of the imprinted
loci showed no or minor abnormalities (e.g. DIRAS3,
GPR1-ZDBF2, MEST, PEG10-SGCE, GRB10), while oth-
ers show consistent hypomethylation (e.g. GNAS) or hyper-
methylation (e.g. RB1 and PEG3). Furthermore, several loci
displayed considerable variation from iPSC-to-iPSC line
(e.g. NAP1L5, FAM50B, PLAGL1 and IGF2-H19) (Figure
4C; Supplementary Table S3). In comparison to previous
reports on imprinted defects in hiPSCs that used methy-
lome techniques (51,52), we obtained overlapping results
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Figure 4. Human IMPLICON in blood, naı̈ve and primed hESCs. (A) Methylation analysis of the KLF4 (unmethylated control), RHOG (methylated
control) and several gDMRs in blood samples from two independent individuals; Graph represents the mean ± SD methylation levels measured at each
CpG within each genomic region for each individual blood sample (sample 1: dark colours; sample 2: light colours); dashed line marks 50% level of
methylation. (B) Plot displaying methylated and unmethylated CpGs for each CpG position (in columns) in all the individual reads (in rows) for GRB10
and IGF2-H19 for each individual blood sample (Sample 1 and 2). (C) Methylation analysis of the unmethylated (KLF4), methylated (RHOG) controls
and several gDMRs in naı̈ve and primed hESCs; Graph represents the mean ± SD methylation levels measured at each CpG within each genomic region;
primed hESCs shown here are an average of two replicates, whereas for naı̈ve hESCs only one sample was analysed; dashed line marks 50% level of
methylation. (D) Plot displaying methylated and unmethylated CpGs for each CpG position (in columns) in all the individual reads (in rows) for GRB10
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Figure 5. Human IMPLICON in donor fibroblasts and hiPSCs from an Angelman patient and healthy donor. (A) Schematic representation of the PWS/AS
locus on chr15q11–13 in human neurons, in control (healthy donor) and Angelman patient (harbouring a 4.8 Mb deletion of the maternal PWS/AS locus);
SNURF TSS-DMR is the ICR of this region; red arrows – primers to amplify SNURF TSS-DMR; genomic region not drawn to scale. (B) Methylation
analysis of the SNURF TSS-DMR in donor fibroblasts and hiPSCs from an Angelman patient and healthy donor; Graph represents the mean ± SD
methylation levels measured at each CpG within the SNURF TSS-DMR for each sample. (C) Methylation analysis of several imprinted regions (GRB10,
GNAS, RB1, IGF2-H19 and IGF2R) in donor fibroblasts and hiPSCs from an Angelman patient and healthy donor; Graph represents the mean ± SD
methylation levels measured at each CpG within the SNURF TSS-DMR for each sample.
PLAGL1 and GNAS), hypermethylation (e.g. PEG3), as
well as, normal maintenance of imprinting (e.g. MEST and
PEG10) (Supplementary Table S4). The HERC3-NAP1L5
locus shows divergent results, however, no consistent results
were observed for this locus among the previous reports
(Supplementary Table S4). Overall, our IMPLICON tech-
nique identified methylation defects in gDMRs of hiPSCs
consistent with previous reports highlighting its potential
application in identifying imprinted defects in the context
of human imprinted regions.
DISCUSSION
We present IMPLICON to examine DNA methylation pat-
terns at imprinted regions with an unprecedented coverage.
We designed a set of primers to study both murine and hu-
man imprinted clusters, the former with allelic resolution.
This method surpasses many shortcomings, such as time
and cost of other methodologies to look at parental allele-
specific methylation (Supplementary Table S1). We believe
IMPLICON will provide an added value to the imprinting
community and could become the gold standard for methy-
lation inspection at multiple imprinted regions for both re-
search and diagnostics.
IMPLICON is an adaptation of amplicon-bisulfite se-
quencing method assessing multiple imprinted regions and
handling several samples in a single MiSeq run. Conse-
quently, it outperforms commonly used DNA methylation
analysis methods in many ways (Supplementary Table S1).
Firstly, it is much less laborious and more high-throughput
than bisulfite-PCR Sanger sequencing and pyrosequenc-
ing methods traditionally used to look at methylation in
imprinted regions. IMPLICON yields considerably richer
datasets with over 100-fold increment in the coverage of
amplicons analysed (compared to bisulfite-PCR Sanger se-
quencing) over a longer stretch of CpGs (compared to py-
rosequencing). Furthermore, the costs compared to whole
genome bisulfite sequencing, RRBS and array-based meth-
ods makes our approach much more appealing. Moreover,
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our approach with nucleotide and allelic resolution is not
matched by any of these bisulfite-based methods. Finally,
given the reduced costs and ultra-deep genomic coverage,
IMPLICON could be easily scalable to include more ge-
nomic regions of interest and more samples.
In recent years, new technological advances enabled the
emergence of bisulfite-free methods for DNA methylation
analysis such as EM-seq or TAPS-seq (29–31) which, un-
like bisulfite-based methods, are capable of distinguishing
5′methyl-cytosine (5mC) from 5′hydroxymethyl-cytosine
(5hmC). However, as there are no parental-allele specific
differences in 5hmC at ICRs (29) our simpler and cheaper
bisulfite-based amplicon method will accurately detect im-
printing aberrations. Another advantage of these methods
is the reduced DNA fragmentation allowing for long-read
sequencing (29,31). However, library preparation and se-
quencing costs are still prohibitive for a multiplex and scal-
able approach such as IMPLICON. In conclusion, we be-
lieve our IMPLICON method is the most cost-effective,
scalable, rapid and ultra-deep approach that will best serve
the epigenetic community at analysing methylation at mul-
tiple imprinted regions.
The mouse remains the favorite animal model for study-
ing the underlying mechanisms of imprinting regulation (re-
viewed in (1)). For example, the use of mouse models al-
lowed the identification of ZFP57 and ZFP445 KRAB zinc-
finger proteins as fundamental protection factors of methy-
lation imprints at critical developmental stages (56,57).
Therefore, inspection of methylation remains highly rele-
vant for murine imprinted regions. Our initial set of primers
designed on the murine reference genome (C57BL/6) con-
sisted of 15 primers covering 9 imprinted regions. Of note,
we have previously used a subset of these primers to re-
port loss of methylation at imprinted regions in 2C-like
(MERVL+Zscan4+) mouse ESCs (58), attesting for the util-
ity of our method. The additional primers designed for
allele-specific IMPLICON are also suitable to analyse im-
printed loci in C57BL/6 inbred mice, which increased the
number of primers to 25 covering a total of 15 imprinted
clusters. This set of IMPLICON primers could, therefore,
be used to look at imprinting maintenance in particular cir-
cumstances (e.g. environmental insult or genetic ablation)
in cells or animals of the C57BL/6 background. Most of
the primer pairs will also be suitable for imprinting analy-
sis of other phylogenetically close strains commonly used as
laboratory mice (e.g. 129/SvJ).
For imprinting studies, the use of reciprocal crosses be-
tween genetically distant mouse strains is of particular util-
ity, since it allows for allele-specific DNA methylation and
gene expression analyses based on DNA sequence polymor-
phisms (22,46). Importantly, our method preserves allelic
information for the most commonly used BL6 × CAST
cross and, moreover, it does so with ultra-deep allelic cov-
erage (∼20 000-fold was achieved). Allele-specific IMPLI-
CON has now been optimized for 13 ICRs and future work
will surely expand this set for the rest of ICRs in this hybrid
cross. This could also be envisioned for other hybrid crosses
(e.g. BL6 versus Mus musculus molossinus JF1) (59), com-
monly used in imprinted studies using our defined criteria
for primer design (see Materials and Methods). With the
ultra-deep allelic coverage achieved, we believe our method
will be better at discerning subtle parental allele-specific
methylation changes as a result of environmental perturba-
tions, pathological conditions or ageing, which might never
have been sufficiently appreciated using other less powerful
imprinting assays (Supplementary Table S1).
Diagnostics in human medicine is undoubtedly an area
where analysis of imprinting methylation is important. Be-
sides the 8 syndromes currently characterized for which
the affected imprinted loci have been identified, some pa-
tients have recently been shown to display multi-locus im-
printing disturbances (MLIDs). MLIDs are characterized
by epimutations in several imprinted loci and clinical man-
ifestations of, at least, one imprinting disorder (reviewed
in (11)). Screening for MLIDs, that might remain under-
diagnosed, is an obvious application for our human IM-
PLICON method which currently covers most of the hu-
man imprinted regions and could be extended to all re-
gions, including the DLK1-DIO3 region in the near fu-
ture. Moreover, our IMPLICON method provides an easy
and quick diagnostic tool not only for MLIDs, but also
for other human conditions where altered imprinting is ex-
pected to be implicated, namely fetal growth restriction or
cancer.
Another instance where inspection of imprinting methy-
lation is becoming fashionable is in stem cell biology. In-
deed, genomic imprinting has been shown to gain distorted
patterns through stem cell conditions and upon reprogram-
ming of somatic cells into hiPSCs. This creates an epige-
netic obstacle for their correct use in disease modelling and
their application in regenerative medicine (38,50–52,54).
In contrast to blood samples and primary dermal fibrob-
last, hESCs and hiPSCs exhibit several imprinting defects
consistent with the reports in the literature (Supplemen-
tary Table S4) (55). This was exacerbated when hESCs
were grown in naı̈ve conditions, where loss of methylation
in imprinted regions followed the globally reduced levels
of DNA methylation typical of cells grown in these cul-
ture conditions (47,49). Our results show the ability of the
IMPLICON method to detect these methylation deficien-
cies in human stem cells. Since epigenetic stability in stem
cells remains an issue and genomic imprinting provides
an excellent thermostat of epigenetic fidelity, IMPLICON
emerges as a simple and fast method for routine screen-
ing of hESC/hiPSCs ahead of their use in downstream
applications.
In summary, we present a rapid method to measure
imprinting methylation in a high-throughput and cost-
effective manner that surpasses the limitations of other
high-throughput sequencing methods when imprinting in-
spection is at stake (Supplementary Table S1). With further
developments, IMPLICON could easily cover all known
ICRs. Importantly, the guidelines and rules presented are
extensive to screen DNA methylation profiles in any other
genomic regions where high coverage is desired. With un-
precedented coverage and nucleotide resolution, IMPLI-
CON could become a gold-standard method to profile
imprinting methylation in laboratory and clinical settings
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